NM-IL-12

· Neumedicines Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NM-IL-12, covering 2018-11-16 to 2018-11-16. Get the full timeline:

Most recent: Clinical Trial Update: NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) [Phase 2]